Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALIPERIDONE vs PANITUMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PALIPERIDONE vs PANITUMUMAB: Safety Overview

Metric PALIPERIDONE PANITUMUMAB
Total FAERS Reports 40,949 10,876
Deaths Reported 1,809 1,666
Death Rate 4.4% 15.3%
Hospitalizations 8,499 3,121
Average Patient Age 38.9 yrs 63.0 yrs
% Female Patients 33.6% 36.9%
FDA Approval Date Apr 6, 2018 N/A
Manufacturer Alembic Pharmaceuticals Limited Amgen Inc
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription